Pure Global

Aushi Ammycin 30 mcg paper ingots - Taiwan Registration ed9c371a06d24f695478d7a7cd70e34f

Access comprehensive regulatory information for Aushi Ammycin 30 mcg paper ingots in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ed9c371a06d24f695478d7a7cd70e34f and manufactured by OXOID LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
ed9c371a06d24f695478d7a7cd70e34f
Registration Details
Taiwan FDA Registration: ed9c371a06d24f695478d7a7cd70e34f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Aushi Ammycin 30 mcg paper ingots
TW: ๅ‚ฒไธ– ๅฎ‰้ปด็ด 30ๅพฎๅ…‹็ด™้Œ 
Risk Class 2
Cancelled

Registration Details

ed9c371a06d24f695478d7a7cd70e34f

DHA00601615002

Company Information

United Kingdom

Product Details

It is used as an antibiotic susceptibility test for amphecline.

C Immunology and microbiology

C.1620 ๆŠ—่Œๆ„Ÿๅ—ๆ€ง่ฉฆ้ฉ—็›ค

import

Dates and Status

Mar 15, 2006

Mar 15, 2011

Nov 08, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ